2017 May 08
Two Weill winners of Pershing Square Sohn Prize
Juan Cubillos-Ruiz and Yimon Aye were among six scientists selected as prestigious Pershing Square Sohn Prize winners. Read more
2017 May 05
New Method Developed to More Accurately Model Colorectal Cancer
Researchers have long struggled to develop preclinical models of colorectal cancer in which the disease forms in the correct anatomical location. Now Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center... Read more
2017 May 05
Patient preferences with MCL treatment
Peter Martin, M.D., assistant professor of medicine, discusses preferences patients have for treatment of their mantle cell lymphoma (MCL). Read more
2017 May 05
Emergence of CAR T-cell therapy in hematologic cancers
John P. Leonard, M.D., discusses the emergence and potential of chimeric antigen receptor (CAR) T-cell therapy across hematologic malignancies. Read more
2017 May 05
New method developed to more accurately model colorectal cancer
Using stem cells and three-dimensional organoids, Lukas Dow, Ph.D., and colleagues have created a colon cancer model that more accurately reflects the progression of the disease. Read more
2017 May 05
Pioneering program teaches students how to commercialize medical technologies
Graduate student Neel Madhukar came in second place in an entrepreneurship competition for medical technologies. Read more
2017 May 05
Collaborative startup will monitor pathogens in hospital settings
Feature about Biotia, a startup offering microbial surveillance for hospitals, is a joint venture between Christopher Mason and colleagues at Cornell Tech. Read more
2017 May 02
Delaying starting age for mammography won’t reduce overdiagnoses
A survey of almost six million breast exams found not one case of untreated cancer had regressed by the next mammogram—refuting the notion that overdiagnosis could be reduced by delaying the starting age for mammography screening or increasing the interval between exams. Read more
2017 May 02
Ongoing studies in the neoadjuvant setting for RCC
David M. Nanus, M.D., discusses ongoing studies in the neoadjuvant setting for patients with renal cell carcinoma (RCC). Read more
2017 May 02
The difference in treatment of left- and right-sided tumors in CRC
Manish A. Shah, M.D., discusses the difference in treatment of left- and right-sided tumors in colorectal cancer (CRC). Read more
2017 May 01
Needle in a Haystack
Video series follows Gail Roboz, Monica Guzman, Duane Hassane and the leukemia team as they tackle AML. Read more
2017 Apr 28
WorldQuant Initiative for Quantitative Prediction Established at Weill Cornell Medicine
NEW YORK (April 28, 2017) – Weill Cornell Medicine today announced a gift made by WorldQuant, LLC (“WorldQuant”) and Igor Tulchinsky that will further realize the promise of precision medicine. The $5 million gift... Read more
2017 Apr 28
Hitting Her Stride
Profile of Lisa Roth, M.D., as an oncologist, cancer survivor and distance runner Read more
2017 Apr 28
WorldQuant Initiative for Quantitative Prediction established at Weill Cornell Medicine
A $5 million gift will establish a new initiative to use predictive tools to enhance Weill Cornell Medicine’s precision medicine efforts. Read more
2017 Apr 28
Immune cells play crucial role in brain cancer development
Brain tumors recruit immune cells derived from bone marrow to transform what began as benign masses into deadly malignancies, according to studies led by Jeffrey Greenfield, M.D., Ph.D. Read more
2017 Apr 26
Five Weill Cornell medical students win prestigious Howard Hughes Fellowships
Several cancer projects will get a boost thanks to prestigious research fellowships from the Howard Hughes Medical Institute. Read more
2017 Apr 21
This professor will march to remind the world why government should support scientific exploration
Harold Varmus, M.D., explains "the profound need to reassert public support for rational thought." Read more
2017 Apr 20
We Are Weill Cornell Medicine: Dr. Adrienne Phillips
Profile of Adrienne Phillips, M.D., as part of the #WeAreWCM campaign. Read more
2017 Apr 18
Obinutuzumab vs. rituximab weighed as follicular lymphoma therapy
John Leonard, M.D., discusses the optimal follicular lymphoma treatment. Read more
2017 Apr 17
New study challenges diagnostic approach for common urological condition
Combining kidney ultrasound with a visual examination of the bladder and urethra appears to be the most cost-effective way to screen for cancers of the genitourinary tract in people with microscopic amounts of blood in their urine, according to Weill Cornell urologists Read more
